DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Lexicon Pharmaceuticals Q4 EPS $(0.48) Beats $(0.77) Estimate, Sales $8.727M Miss $10.26M Estimate

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.77) by 37.66 percent. This is a 200 percent decrease over losses of $(0.16) per share

Benzinga · 03/12/2020 11:11

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.77) by 37.66 percent. This is a 200 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $8.727 million which missed the analyst consensus estimate of $10.26 million by 14.94 percent. This is a 48.88 percent decrease over sales of $17.071 million the same period last year.